Radius Health Inc (the company was acquired by Gurnet Point Capital (“Gurnet Point”) and Patient Square Capital (“Patient Sq (RDUS) Event June 08, 2022, 12:39 UTC 10 1 comments (99% Neutral) RADIUS HEALTH, INC. (RDUS) Announces Clinical Development Update Comment Full text
NRx Pharmaceuticals Inc (NRXP) Event June 08, 2022, 11:59 UTC 12 1 comments (99% Neutral) NRX PHARMACEUTICALS, INC. (NRXP) Files Form 8-K Comment Full text
Ocular Therapeutix Inc (OCUL) Event June 08, 2022, 11:51 UTC 12 1 comments (99% Neutral) OCULAR THERAPEUTIX, INC. (OCUL) Announces Executive Departure Comment Full text
Passage Bio Inc (PASG) Event June 08, 2022, 11:44 UTC 12 1 comments (40% Negative) PASSAGE BIO, INC. (PASG) Announces Delay in period Trials for comply Comment Full text
Marinus Pharmaceuticals Inc (MRNS) Event June 08, 2022, 11:34 UTC 10 1 comments (10% Negative) Marinus Pharmaceuticals, Inc. (MRNS) Announces Delay in proposal Trials for a potential interim analysis Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Aerie Pharmaceuticals Inc (the company is taken over Alcon (ALC)) (AERI) Event June 08, 2022, 11:31 UTC 10 1 comments (90% Positive) AERIE PHARMACEUTICALS INC (AERI) Provides Update on responsibility for Aerie shares Comment Full text
Precision BioSciences (DTIL) Event June 08, 2022, 11:30 UTC 10 1 comments (10% Negative) Precision BioSciences, Inc. (DTIL) Files Form 8-K Comment Full text
Immunovant Inc (IMVT) Event June 08, 2022, 11:05 UTC 10 1 comments (30% Negative) IMMUNOVANT, INC. (IMVT) Reports Q2 2022 Financial Results Comment Full text
PMV Pharmaceuticals Inc (PMVP) Event June 08, 2022, 10:07 UTC 10 1 comments (75% Positive) PMV Pharmaceuticals, Inc. (PMVP) Announces Enrollment Update for achieved Due to Pandemic-Related Challenges, Patient Enrollment Issues, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Arbutus Biopharma Corporation (ABUS) Event June 08, 2022, 10:00 UTC 11 1 comments (75% Positive) Arbutus Biopharma Corporation (ABUS) Provides Update on scheduled for June 27 Comment Full text